Integrated public single cell re-analysis reveals rare intermediate cell type in neurodegenerative disease
KEYWORDS: scRNA-Seq & bulk RNA-seq | Therapeutic targets discovery | Public datasets | Neurodegenerative disorder | Oligodendrocytes
Challenge
BISC’s customer is involved in remyelination research. Remyelination is a key process to heal the brain after traumatic or disease-related injury. Uncovering driver mechanisms could result in therapeutic targets for chronic neurodegenerative disease where remyelination fails.
Solution
Integration of multiple public single-cell RNA repositories, combined with extensive downstream analysis, trajectory analysis and regulatory network inference.
Impact
- Clarification of differentiation process beyond the state-of-the-art
- Creation of a unique data repository to mine for novel markers
- Confirmation and discovery of new therapeutic targets
Do you want to discuss your project?
Our team at your nearest BISC Global office will be happy to assist you.
Check our other Resources on Single Cell & Transcriptomics: